Jain's main research interest is tumor pathophysiology, including tumor microcirculation, heat and mass transport in tumors, pharmacokinetics, and dynamics of thin films and membranes. The move from Carnegie Mellon, an institution with a strong emphasis on engineering education, to a medical school will provide "closer interaction with basic scientists and clinicians," he says.
Jain says that in Boston, his research team will be multidisciplinary, as it was at Carnegie Mellon ("Hot Team," The Scientist, Oct. 15, 1990, page 20). "A lot of my senior people are moving with me," he says; among them will be an immunologist, a pathologist, a biomedical engineer, and a chemical engineer. "And I have a surgeon coming from Germany, and a radiation biophysicist coming from the University of Minnesota." In addition to his work in Boston, Jain says, "I'm leaving several people behind [at Carnegie Mellon] to continue our work; that | n will be ...
